Professional Documents
Culture Documents
Task
From: Journal of Economic Psychology <joep@elsevier.com>
Date: Wed, Jan 16, 2013 at 7:02 PM
Subject: Thank you for the review of JOEP-D-12-00434
To: <xxxx@columbia.edu>, <xxxx@gmail.com>
You may access your review comments and the decision letter (when available - you will be notified!) by
logging onto the Elsevier Editorial System at url: http://ees.elsevier.com/joep/. Please login as a Reviewer.
You can choose to start your 30 day access period at any time up to 6 months after the date you
accepted the invitation to review.
Kind regards,
GerlindeFellner
Associate Editor
Journal of Economic Psychology
review receipt? Y
(Y/N)
Review Content:
Editor: GerlindeFellner
Editor Email:
2. Task
On 04/08/2014 15:36, "jlr@asbmb.org" <jlr@asbmb.org> wrote:
review receipt? Y
(Y/N)
Review Content:
Editor Email:
3. Task
From: editorial@jove.com
To: xxx@hotmail.com
Date: Fri, 19 Oct 2012 03:35:42 -0400
Subject: Thank you for agreeing to review (JoVE50398)
Dear Dr.Tain,
Thank you for agreeing to review manuscript "5/6th nephrectomy to induce chronic kidney
disease in the rat" for the Journal of Visualized Experiments.
To download the paper now, please click this link: View Submission
You may submit your comments online at the JoVE submission site.
Regards,
reviewreceipt? N
(Y/N)
Journal:
Date of review:
Review Content:
Article title:
Manuscript ID:
Editor:
Editor Email:
4. Task
You-Lin Tain, MD, PhD
Associate Professor, Division of Pediatric Nephrology, Kaohsiung Chang Gung
Memorial Hospital
and Chang Gung University, College of Medicine, Kaohsiung, Taiwan
123 Dabi Road, Niausung, Kaohsiung 83301, Taiwan
E-mail address: xxxx@hotmail.com OR xxxx@adm.cgmh.org.tw
Office Tel: +886-7-7317123 ext. 8723
Tel: +886-975056995
Fax: +886-7-7338009> From: editorial@jbiomedsci.com
> To: xxxx@hotmail.com
> Subject: Review of Journal of Biomedical Science manuscript - Angiotensin-converting
enzyme ...
> Date: Wed, 12 Sep 2012 13:53:55 +0100
>
> Re: Tarek K Motawi Prof, Shohda A El-Maraghy Assis. prof and Mahmoud A Senousy
TA
> Angiotensin-converting enzyme inhibition and angiotensin AT1 receptor blockade
down-regulate angiotensin-converting enzyme expression and attenuate renal injury in
streptozotocin-induced diabetic rats
> Journal of Biomedical Science
>
>Dear Dr Tain,
>
> This is just a quick note to confirm receipt of your review of the above manuscript. In
case it is helpful, you will find a copy of your review at the end of this message. We will
be sending this to the authors as soon as we are able to come to a decision on the
manuscript. You will also find any confidential comments you sent to the editors below.
>
> Thank you for your assistance in reviewing the paper for Journal of Biomedical
Science.
>
> With best wishes,
>
>
> Julie Y.H. Chan
>The Journal of Biomedical Science Editorial Team
>
>e-mail: editorial@jbiomedsci.com
> Web: http://www.jbiomedsci.com/
>
>
> ***********
>
> Reviewer's report: Major Compulsory Revisions
> The authors investigated whether ACEI; enalapril and the ARB; valsartan have
beneficial effects on renal ACE mRNA and protein expression, serum ACE activity and
TGF-β1, and renal oxidative stress to protect the kidney against STZ-induced damage.
The authors concluded that: (1) ACEI and ARB suppress ACE expression; (2)
Hyperglycemia and oxidative stress contribute to ACE up-regulation; and (3) ACEI and
ARB protect the kidney against STZ-induced damage mainly by suppression of ACE
expression and Na+/K+-ATPase activity. There are a number of issues that need to be
addressed.
> 1.The protective role of ACEI/ARB on RAS and the pathophysiology of oxidative
stress/NO have been extensively studied both in STZ-induced and other diabetic animal
models. The present study has only corroborated or confirmed what is already known
and has not provided new or additional information.
> 2.The rat model cited [25] by the authors is totally different from the model used in this
study, including gender (F vs. M), doses of ACEI and ARB, and treatment course (30
days vs. 8 weeks). Any other reference?
> 3.The ACE mRNA expression shown in Fig 1A is determined by end-point RT-PCR
but not the qPCR method as the author described in the Method section.
>
>
> Level of interest: Reject as not of sufficient priority to merit publishing in this journal
>
> Quality of written English: Acceptable
>
> Statistical review: No, the manuscript does not need to be seen by a statistician.
>
>
>
> ***********
>
> Confidential comments to editors: Dear Editor,
> Most results are not novel. I suggest rejection for this manuscript in your journal. In
addition, I am wondering whether this is a resubmitted manuscript
(3798434567494451). There is no significant improvement compared to last version.
> Yours sincerely,
> You-Lin Tain, M.D. Ph.D.
>
>
> What next?: Reject as not of sufficient priority to merit publishing in this journal
>
> Declaration of competing interests: I declare that I have no competing interests.
review receipt? Y
(Y/N)